Palivizumab - CISMeF

Preferred Label : Palivizumab;

MeSH definition : A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.;

CISMeF synonym : 493, MEDI; Antibody MEDI-493, Monoclonal; MEDI-493, Monoclonal Antibody;

DeCS synonym : Monoclonal Antibody MEDI493;

MeSH hyponym : Synagis; MEDI 493; Monoclonal Antibody MEDI-493; Monoclonal Antibody MEDI 493; Monoclonal Antibody MEDI493; MEDI-493; MEDI493;

MeSH Related Number : 188039-54-5;

Wikipedia link : https://en.wikipedia.org/wiki/Palivizumab;

Is substance : O;

UNII : DQ448MW7KS;

Details

Origin ID

D000069455;

UMLS CUI

C0672596;

ATC code(s)
- palivizumab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Palivizumab [ICD-11 Extension code]
CISMeF manual mappings
- Palivizumab [NCIt concept]
- Palivizumab (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- palivizumab [International Nonproprietary Name]
Exact mapping(s) to DCI
- palivizumab [International Nonproprietary Name]
Pharmacological action(s)
- antiviral agents [MeSH Descriptor]
Record concept(s)
- MEDI 493 [MeSH concept]
- Synagis [MeSH concept]
- palivizumab [MeSH concept]
See also inter- (CISMeF)
- Product containing palivizumab (medicinal product) [SNOMED CT concept]
- Synagis [ICD-11 Extension code]
- Synagis [ICHI extension code]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Palivizumab [NCIt concept]
- Palivizumab (substance) [SNOMED CT concept]
- Product containing palivizumab (medicinal product) [SNOMED CT concept]
- palivizumab [ATC Code]
- palivizumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- palivizumab [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients